Stocks Health care MDXH
NASDAQ · Health careMDxHealth SA (MDXH)
MDxHealth SA reported revenue of $107.9M in fiscal 2025, up 19.8% from a year earlier. It posted a net loss of $33.5M. In fiscal 2025 capital spending exceeded operating cash flow by $3.3M. At December 31, 2025 it held $29M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 3, 2026.
What MDxHealth SA does
MDxHealth SA is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker MDXH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $107.9M | -$33.5M | -$0.67 | -$3.3M |
| 2024 | $90M | -$38.1M | -$1.16 | -$19.7M |
| 2023 | $70.2M | -$43.1M | -$1.66 | -$24.2M |
| 2022 | $37.1M | -$44M | -$2.78 | -$36.9M |
| 2021 | $22.2M | -$29M | $2.38 | -$23.4M |
| 2021 | $18.5M | -$28.7M | $3.37 | -$20.8M |
Latest SEC filings
What MDxHealth SA has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026
- August 17, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Activist stake (5% or more) SCHEDULE 13D
- August 13, 2026
- August 13, 2026
- August 13, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 24, 2026
- July 8, 2026Passive stake changed SCHEDULE 13G/A
- July 2, 2026
Questions about MDXH
What does MDxHealth SA do?
MDxHealth SA is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker MDXH.
Is MDxHealth SA profitable?
No. In fiscal 2025 it reported a net loss of $33.5M on revenue of $107.9M.
How much revenue does MDxHealth SA make?
In fiscal 2025 MDxHealth SA reported revenue of $107.9M. That is 19.8% more than a year earlier.
When did MDxHealth SA last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 3, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the planned insider sale from September 17, 2026.
Similar companies
Follow MDXH
Get an email when MDxHealth SA files with the SEC: results, executive changes, material agreements and annual reports.
Follow MDXH: get an email when it filesWhere the numbers come from
Financial figures are the values MDxHealth SA tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.